Gene · 7185
Papers2,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Findings in Teleost TRAF4, a Protein Acts as an Enhancer in TRIF and TRAF6 Mediated Antiviral and Inflammatory Signaling. | Front Immunol | 2022 | 35898509 | PubTator, text mining | PubMed |
| Interplay of Environmental, Individual and Genetic Factors in Rheumatoid Arthritis Provocation. | Int J Mol Sci | 2022 | 35897715 | PubTator, text mining | PubMed |
| Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule. | Comput Struct Biotechnol J | 2022 | 35891784 | PubTator, text mining | PubMed |
| Genetic Biomarkers as Predictors of Response to Tocilizumab in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. | Genes (Basel) | 2022 | 35886067 | PubTator, text mining | PubMed |
| Pharmacological Approaches to Decelerate Aging: A Promising Path. | Oxid Med Cell Longev | 2022 | 35860429 | PubTator, text mining | PubMed |
| RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness. | Front Cell Dev Biol | 2022 | 35859892 | PubTator, text mining | PubMed |
| The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach. | Front Aging Neurosci | 2022 | 35832065 | PubTator, text mining | PubMed |
| LINC00313 alleviates osteoarthritis progression in mice through promoting TRAF1 promoter methylation and inhibiting the ASK1/JNK signaling pathway. | Immunopharmacol Immunotoxicol | 2022 | 35815528 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms. | Cancers (Basel) | 2022 | 35805049 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing. | Cancers (Basel) | 2022 | 35804862 | PubTator, text mining | PubMed |
| Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia. | Cell Death Discov | 2022 | 35778418 | PubTator, text mining | PubMed |
| Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy. | Cancer Immunol Res | 2022 | 35759797 | PubTator, text mining | PubMed |
| TRAP1 Chaperones the Metabolic Switch in Cancer. | Biomolecules | 2022 | 35740911 | PubTator, text mining | PubMed |
| Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target. | Cancers (Basel) | 2022 | 35740492 | PubTator, text mining | PubMed |
| Snail Promotes Cancer Cell Proliferation via Its Interaction with the BIRC3. | Biomol Ther (Seoul) | 2022 | 35711139 | PubTator, text mining | PubMed |
| Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains. | Nat Biomed Eng | 2022 | 35710755 | PubTator, text mining | PubMed |
| Asthma and the Missing Heritability Problem: Necessity for Multiomics Approaches in Determining Accurate Risk Profiles. | Front Immunol | 2022 | 35693821 | PubTator, text mining | PubMed |
| TRAF4 Inhibits the Apoptosis and Promotes the Proliferation of Breast Cancer Cells by Inhibiting the Ubiquitination of Spindle Assembly-Associated Protein Eg5. | Front Oncol | 2022 | 35692762 | PubTator, text mining | PubMed |
| Kidney omics in hypertension: from statistical associations to biological mechanisms and clinical applications. | Kidney Int | 2022 | 35690124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7185/papers?page=19